The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Scirocco repays loan; Vp says rail strikes slow works

Tue, 11th Oct 2022 14:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Scirocco Energy PLC - Leeds, England-based oil & gas investment company - Agrees to pay USD200,000 in the coming days to part settle its outstanding balance of its investment facility with Prolific Basins LLC, a US-based investor. Says the remaining balance of USD245,000 will be paid in five equal monthly instalments of USD49,000 each over the months of November to March 2023. Adds that Prolific has agreed not to request share issuances under the facility, as long as Scirocco complies with the repayment schedule. Says that it will use available cash resources to pay the loan, strengthened by the first cash instalment received from ARA Petroleum Tanzania Ltd. Chief Executive Tom Reynolds says: "Scirocco is pleased to have Prolific's continued support during a challenging time in the global markets, Prolific's investment served as an important bridge in Scirocco's cash flow requirements, and Prolific has acted as a supportive and responsible corporate citizen during its tenure as an investor in Scirocco."

----------

Vp PLC - Harrogate-based equipment rental firm - Continues to trade "satisfactorily", with further growth in the first half its new financial year. Says UK housebuilding and infrastructure activity has been "supportive", whilst the construction market conditions have been stable. However, recent rail strike actions have partially impact some of its planned works, and in HS2, demand has slowed as Phase 2 of the project has experienced delays. HS2 is the high-speed rail line being building between Birmingham and London. Vp says its International division has made "good progress" in the first half of its financial year with both constituent businesses, Airpac Rentals and TR Group, delivering good growth on the prior year. Looking ahead, expects to invest further when market conditions improve. "The board has an exemplary historic record of managing the group and delivering returns through adverse trading conditions most recently in the last global downturn and then in the Covid-19 pandemic," the company asserts. Expects to publish interim results for the six months ended September 30 on November 29 and says these will be in line with its expectations.

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Says the first patient has been dosed in its Phase 2a Trial for RXC007, the company's fibrosis asset. The Phase 2a study is a 12-week multi-cohort, randomised, double-blind, placebo-controlled dose ranging study to assess early signals of efficacy as well as the safety and tolerability of RXC007 in idiopathic pulmonary fibrosis patients. RXC007, dosed orally and therapeutically, was able to significantly reduce skin thickness, fibrosis and collagen deposition in the skin and lungs as measured by hydroxyproline, histological staining and scoring. RXC007 is currently in development for lung fibrosis, including idiopathic pulmonary fibrosis and auto-immune related interstitial lung disease. Expects headline data from the Phase 2a study to be available in the second half of 2023. "The encouraging preclinical and translational data for RXC007 have given us confidence to progress into a Phase 2 programme with IPF as the lead indication," says Chief Executive Lisa Anson.

----------

Panther Metals PLC - Canada-focused mineral explorer - Says preparations at the Obonga project remain on schedule. The Obongo project covers an area of around 251 kilometres squared, providing an 88% coverage of the Obonga Greenstone Belt and comprising five "high priority" prospects for which drilling permits are in place. The Obongo Greenstone Belt is around 160 kilometres north of Thunder Bay, Ontario. Expects construction of helicopter landing zones at the five drill target locations to be complete this week ahead of the planned drilling rig mobilisation. "Our aggressive plans to drill five separate targets containing multiple anomalies flies in the face of conventional thinking in today's junior exploration sector, but this approach offers extraordinary upside combined with the most efficient use of capital," says Chief Executive Darren Hazelwood.

----------

BlueRock Diamonds PLC - South Africa-focus diamond producer - Sells a 10.22 carat stone in its September sale for USD122,888. Chief Executive Victor Dingle says: "Kareevlei continues to yield highly coveted, quality diamonds, which sell at premium prices as highlighted by this recent tender that saw the sale of a 10.22 carat stone for around USD123,000; as our new mine plan develops, we envisage an increasing number of similar discoveries."

----------

MiLOC Group Ltd - Hong Kong-based pharmaceutical and beauty product company - Raises GBP39,585 through the issue of 197,925 new shares at a price of 20 pence each. Says the placing proceeds will be used for general working capital purposes. Following the issue of the new shares, the total number of shares in issue will be 86.3 million. Also calls an annual general meeting to be held on November 2.

----------

By Sophie Rose; sophierose@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 16:02

IN BRIEF: Redx Pharma shareholders approve AIM delisting plans

Redx Pharma PLC - clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve cancelling shares on AIM in London. This is now expected to take place on May 1, with last day of trading on April 30. Says it remains the company's intention to provide a matched bargain facility to assist shareholders wishing to trade in shares following the AIM delisting. Says it will make further details available in "due course" on its website.

Read more
12 Apr 2024 15:35

Director dealings: Redx Pharma CEO ups stake

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Read more
2 Apr 2024 16:57

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

Read more
2 Apr 2024 12:15

Redx Pharma plummets on plans to delist from AIM

(Alliance News) - Redx Pharma PLC shares fell on Tuesday, after it said it intends to cancel its shares from trading on AIM in London.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:50

AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2024 09:34

IN BRIEF: Redx Pharma clarifies not currently pursuing US listing

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Responds to a Times article published on Tuesday saying RedX is looking to list its shares in New York. Redx says it "wishes to clarify that it is not currently in any process relating to a listing in the US, nor any other jurisdiction".

Read more
7 Feb 2024 11:08

Redx Pharma shares skyrocket on deal to sell inhibitor program

(Alliance News) - Redx Pharma PLC on Wednesday said it has struck a deal to sell Kirsten rat sarcoma virus inhibitor program to Dublin-based Jazz Pharmaceuticals PLC.

Read more
7 Feb 2024 09:29

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Oct 2023 12:30

Redx Pharma looks to progress portfolio after raising GBP14.1 million

(Alliance News) - Redx Pharma PLC on Wednesday said that it has conditionally raised around GBP14.1 million by way of a subscription for 54.1 million shares at 26 pence each.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:33

Redx Pharma says RXC007 receives orphan drug designation from US FDA

(Alliance News) - Redx Pharma PLC on Monday said its RXC007 drug has received orphan drug designation from the US Food & Drug Administration for the treatment of idiopathic pulmonary fibrosis, a condition causing breathing difficulty due to lung scarring.

Read more
21 Aug 2023 07:43

LONDON BRIEFING: Crest Nicholson lowers annual profit forecast

(Alliance News) - Stocks in London are called flat on Monday, with little in the way of economic data or company updates to reignite risk appetite.

Read more
10 Jul 2023 11:22

Redx Pharma extends term of outstanding notes with two lenders to 2024

(Alliance News) - Redx Pharma PLC on Monday said it extended the term of its outstanding convertible loan notes issued to two lenders RM Special Holdings 3 LLC, otherwise known as Redmile, and Sofinnova Crossover I SLP by a year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.